347
Participants
Start Date
November 30, 2008
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
Indacaterol 150 μg capsules
Indacaterol was supplied in powder filled capsules with a single dose dry powder inhaler (SDDPI).
Indacaterol 300 μg capsules
Indacaterol was supplied in powder filled capsules with a single dose dry powder inhaler (SDDPI).
Placebo capsules
Placebo was supplied in powder filled capsules with a single dose dry powder inhaler (SDDPI).
Novartis Investigator Site, Hong Kong
Novartis Investigator Site, New Territories
Novartis Investigative Site, Ahmedabad
Novartis Investigator Site, Bangalore
Novartis Investigative Site, Coimbatore
Novartis Investigator Site, Coimbatore
Novartis Investigator Site, India
Novartis Investigative Site, Mumbai
Novartis Investigative Center, Panjim
Novartis Investigative Site, Asahikawa
Novartis Investigative Site, Bunkyō City
Novartis Investigator Site, Gifu
Novartis Investigator Site, Himeji
Novartis Investigator Site, Hiroshima
Novartis Investigator Site, Iwata
Novartis Investigator Site, Kanazawa
Novartis Investigative site, Kawasaki
Novartis Investigator Site, Kishiwada
Novartis Investigator Site, Kitakyushu
Novartis Investigator Site, Kochi
Novartis Investigator Site, Koga
Novartis Investigative Site, Kurume
Novartis Investigator Site, Kyoto
Novartis Investigative Site, Maebashi
Novartis Investigator Site, Matsusaka
Novartis Investigative Site, Morioka
Novartis Investigator Site, Nagaoka
Novartis Investigator Site, Nagoya
Novartis Investigative Site, Noda
Novartis Investigative Site, Obihiro
Novartis Investigator Site, Sakai
Novartis Investigative Site, Sapporo
Novartis Investigator Site, Sendai
Novartis Investigator Site, Seto
Novartis Investigator Site, Tenri
Novartis Investigative site, Tokyo
Novartis Investigator Site, Toyonaka
Novartis Investigator Site, Ube
Novartis Investigator Site, Wakayama
Novartis Investigator Site, Yabu
Novartis Investigator Site, Yanagawa
Novartis Investigator Site, Yokkaichi
Novartis Investigative Site, Yokohama
Novartis Investigator Site, Singapore
Novartis Investigator Site, Daegu
Novartis Investigator Site, Junggu
Novartis Investigative Site, Kangwon-Do
Novartis Investigator Site, Pusan
Novartis Investigative Site, Seoul
Novartis Investigator Site, Seoul
Novartis Investigator Site, Chiayi City
Novartis Investigator Site, Kaohsiung City
Novartis Investigative Site, Keelung
Novartis Investigative Site, Linkou District
Novartis Investigative Site, Taichung
Novartis Investigator Site, Taichung
Novartis Investigative Site, Taipei
Novartis Investigator Site, Taipei
Novartis Investigator Site, Taipei County
Novartis Investigator Site, Xindian District
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY